GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 139 days ( -0.97 % )
Last Price $6.22 0 %
High/ Low $6.22 - $6.22 0%
Chg 7 Days N/A $6.22 $6.22
Chg 30 Days N/A $6.22 $6.22
Chg 12 mos 46.70 % $4.24 $6.22
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 59.13 % Width: 67.95 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $7.75 - $13.02 24.61 % - 109.28 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Buy 2022-08-17 - 113 days
Long MA avg 12 mos Buy 2022-07-08 - 141 days
Short/Long MA avg 12 mos Buy 2022-07-13 - 138 days
Pivot Short Sell 2023-01-26 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About La Jolla Pharmaceutical Company

La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age ... LJPC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT